
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Warts: what works, what doesn’t? From duct tape to intralesional bleomycin, here are the fact facts you need to help your patient.
Warts: what works, what doesn’t? From duct tape to intralesional bleomycin, here are the fact facts you need to help your patient.
For more webinar videos,






